As we enter the third year of the COVID-19 pandemic, policy makers need pragmatic data
about the performance of the different vaccination regimens for informed decisions and …

Over the past two decades, vaccination programmes for vaccine-preventable diseases
(VPDs) have expanded across low-and middle-income countries (LMICs). However, the rise …

By the mid of June 2021, after an almost 1.5-year-long COVID-19 pandemic that has
significantly affected the world in multiple ways, various vaccines against COVID-19 have …

Background: COVID-19 vaccines have been released, giving a major hope of getting rid of
the dark pandemic crisis. The availability of vaccines does not necessarily mean that the …

Background The lack of precise definitions and terminological consensus about the impact
studies of COVID-19 vaccination leads to confusing statements from the scientific community …

Acceptance of the COVID-19 vaccine will play a crucial role in combating the current
pandemic. Vaccine rollouts have started in most countries. To reach the desirable vaccine …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and
spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine …

The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a
vaccine to be available within 6 months. So who should be prioritized for vaccination when …

Initial optimism regarding the development of COVID-19 vaccines has been tempered by the
emergence of new variants of SARS-CoV-2. Will vaccination be able to contain the …

The social and behavioural determinants of COVID-19 vaccination have been described
previously. However, little is known about how vaccinated people use and rate their health …